50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
#297,141 of 457,328 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. NULIBRY® (fosdenopterin) for injection just got measured.
4/10 means NULIBRY® (fosdenopterin) for injection is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
NULIBRY approved for molybdenum cofactor deficiency (MoCD) Type A. See Important Safety Information, Instructions for Use, full Prescribing Information on website.
Industry: Healthcare
nulibry.com2
Structured Data
6
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for NULIBRY® (fosdenopterin) for injection.
Scored by Engagemii on July 4, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/nulibry
Cite this score: Engagemii (2026). "AEO Score for NULIBRY® (fosdenopterin) for injection." Retrieved from https://engagemii.com/aeo/brands/nulibry
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform